Status:
COMPLETED
Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)
Lead Sponsor:
Bar-Ilan University, Israel
Conditions:
Diagnosis of Schizophrenia Spectrum Disorders
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
People with schizophrenia spectrum disorders are faced with significant metacognitive impairments that include difficulties in their ability to form complex representations of the self and others. The...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia spectrum disorders
- Ability to provide informed consent
- Ability to read and write in Hebrew
Exclusion
- No co-morbid nuerological condition
- No hospitalization in the last 6 months
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03427580
Start Date
March 1 2018
End Date
August 1 2021
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bar-Ilan University
Ramat Gan, Israel